Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (2)

2023

  1. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1

2016

  1. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer

    Oncotarget, Vol. 7, Núm. 11, pp. 12904-12916